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Week 12 vs. Baseline Percent change (95% CI) -17.8 (-26.0, -8.7) -13.1 (-20.0, -5.6) -25.9 (-33.1, -18.0) -25.9 (-32.9, -18.1) -28.5 (-36.3, -19 .8) 
Week 18 Mean (95% CI) 242.9 (215.4, 273.9) 228.4 (191.3, 272.6) 236.1 (198.5, 280.8) 205.2 (175.8, 239.4) 191.9 (164.8, 223 .5)
Week 24 
Week 13 vs.
Week 12
Percent change (95% CI) a 4.2 (-3.6, 12.6) -1.2 (-9.5, 7.9) 4.9 (-3.3, 13.7) 2.2 (-5.5, 10.6) -4.1 (-11.1, 3.4)
Week 18 vs.
Week 12 Percent change (95% CI) 16.8 (6.1, 28.5) -1.2 (-11.4, 10.2) 9.3 (-2.1, 22.1) 2.8 (-8.3, 15 .3) 3.7 (-6.1, 14.4) (N=102) (N=77) (N=72) (N=73) (N=72)
Week 24 vs.
Week 12 Percent change (95% CI) 10.1 (-0.0, 21.1) 3.0 (-7.7, 14.9) 6.1 (-6.6, 20.6) 12.8 (-0.7, 28.1) 11.0 (-0.5, 23.8)
